VRDN – viridian therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Viridian Therapeutics price target lowered to $36 from $40 at Truist [Yahoo! Finance]
Viridian Therapeutics (VRDN) had its price target lowered by Wedbush from $37.00 to $31.00. They now have an "outperform" rating on the stock.
A Look At Viridian Therapeutics (VRDN) Valuation After A Sharp Multi-Month Share Price Pullback [Yahoo! Finance]
Viridian Therapeutics (VRDN) had its price target lowered by The Goldman Sachs Group, Inc. from $36.00 to $31.00. They now have a "buy" rating on the stock.
Viridian Therapeutics (VRDN) had its price target lowered by Royal Bank Of Canada from $42.00 to $30.00. They now have an "outperform" rating on the stock.
Form ARS Viridian Therapeutics, For: Dec 31
Form DEFA14A Viridian Therapeutics,
Form DEF 14A Viridian Therapeutics, For: Jun 02
Form 8-K Viridian Therapeutics, For: Mar 30
Form SCHEDULE 13G/A Viridian Therapeutics, Filed by: VANGUARD GROUP INC
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.